4.4 Article

Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour

Journal

JOURNAL OF CLINICAL PATHOLOGY
Volume 57, Issue 4, Pages 422-425

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jcp.2003.012344

Keywords

-

Categories

Funding

  1. NIAAA NIH HHS [AA12817, R01 AA012817] Funding Source: Medline

Ask authors/readers for more resources

Background: Desmoplastic small round cell tumour (DSRCT) is a rare and often fatal abdominal tumour that is distinguished by well defined islands of cells, surrounded by prominent desmoplastic stroma. As in certain other tumours, the function of the Wilms's tumour protein (WT1) in repressing gene transcription is lost in DSRCT. Aims: To assess the expression and localisation of connective tissue growth factor (CCN2) in DSRCT because this protein is transcriptionally repressed by WT1 and is associated with the production of abundant extracellular matrix. Methods: CCN2 was assessed by in situ hybridisation and immunohistochemistry. Results: CCN2 mRNA and protein were colocalised to the tumour cells themselves, in addition to stromal fibroblasts and vascular endothelial cells. Conclusions: These data show that CCN2 is produced in high amounts by several cell types in DSRCT, and highlight a potential role for this factor in the autocrine and paracrine regulation of tumour cell growth, matrigenesis, and angiogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available